Trafalgar International, Inc. SEC filings TRFA
Trafalgar International, Inc. has 144 filings in SEC EDGAR's recent list, going back to Jun 20, 2017. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (bylaw or fiscal year change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14C | Information statement | Nov 5, 2026 | Nov 5, 2026 |
| PRE 14C | Filing | Oct 14, 2026 | Oct 14, 2026 |
| DEF 14C | Information statement | May 16, 2025 | May 16, 2025 |
| PRE 14C | Filing | May 6, 2025 | May 6, 2025 |
| PRE 14A | Preliminary proxy statement | Nov 21, 2022 | Nov 21, 2022 |
| DEF 14C | Information statement | Jul 22, 2020 | Jul 22, 2020 |
| PRE 14C | Filing | Jun 18, 2020 | Jun 18, 2020 |
| PRE 14C | Filing | Aug 5, 2019 | Aug 5, 2019 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRFA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1695473
- Former names
- Greater Cannabis Company, Inc. (until Jul 31, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.